Praxair

Praxair, Inc. (NYSE: PX), an industrial gas supplier, announced on Thursday it has entered into multiple transactions and acquired five industrial gas businesses. The five businesses combine for more than $40 million in sales in 2015. The acquisitions is expected to help the company grow its...

Piper Jaffray reiterated its Neutral rating on Praxair (NYSE: PX). At the same time, the rating agency raised its price target on the company's stock from $106 to $107. On Wednesday, PX lost 2.15% of its value to end the day at $101.69.

According to Bank Of America, Praxair (NYSE: PX) held an investor event. Bank Of America said that it attended Praxair's investor event in Chicago, where CEO Steve Angel, CFO Jim Sawyer and senior management highlighted double-digit growth prospects for hydrogen (7% of total sales in 2010) and...

Jefferies is out with its report today on Praxair (NYSE: PX), reiterating Buy. In a note to clients, Jefferies writes, "Praxair's recent announcement of two HyCO projects for Valero could add, by our estimates, $0.07-$0.08 to 2013E EPS, and likely almost double the value of HyCO projects in...

Morgan Stanley has upgraded Praxair (NYSE: PX) from Underweight to Equal-weight and has raised the price target from $103 to $112.

Praxair Inc. (NYSE: PX) remains “one of our favorite long-term growth stocks as the strong fundamentals of the industrial gas business model coupled with management's solid execution has delivered attractive returns so far in the cycle,” Citi reports. “In our meeting with CEO Steve Angel, we were...

In a report published by Piper Jaffray, Praxair (NYSE: PX) is moving to Neutral on valuation. Piper Jaffray said that it is moving the rating on Praxair to Neutral from Overweight as it believes the current valuation fully reflects the strong global industrial outlook, and at this time it...

Jefferies & Company has raised the price target on Praxair (NYSE: PX) from $113 to $122 and maintains its Buy rating.

Piper Jaffray has downgraded Praxair (NYSE: PX) from Overweight to Neutral and has raised the price target from $104 to $106.

Credit Suisse is raising its 12-month price target on shares of Praxair, Inc. (NYSE: PX) to $110 (from $98), reflecting a 10.9X multiple on its 2012 EBITDA estimate with free cash generated going to net debt reduction in the valuation calculation. “Overall, we believe PX is a best in Class Company...

Jefferies is raising its target price of Praxair, Inc. (NYSE: PX) from $105 to $110, along with an increase in the company's estimates. “We remain comfortable Praxair should meet or beat our $1.21 estimate for the quarter,” Jefferies writes. “We are raising our 2011 EPS $0.10 to $5.30, raising 2012...

Jefferies & Company has raised the price target on Praxair (NYSE: PX) from $106 to $110.

JP Morgan has published a research report on Ecolab, Inc. (NYSE: ECL) and has upgraded the company from Neutral to Overweight. In the report, JP Morgan writes "Ecolab stands out as one of the poorer performing equities among the 36 Chemical companies we regularly track, ranking 32nd out of 36 in...

Praxair, Inc.'s (NYSE: PX) 3Q results reflected a continued pickup in emerging markets, led by China and India, Citigroup reports. “Record-setting volumes in China and 15% volume growth in India were meaningful contributors to Asia's 17% volume growth,” Citigroup writes. “PX managed to post a...